NCT03725956 Polysomnographic Findings in Nasal Polyposis
| NCT ID | NCT03725956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Chronic Rhinosinusitis With Nasal Polyps |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2019-01-17 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2019-01-17 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Nasal polyposis (NP) is a chronic inflammatory disease of the nasal and sinus mucosa leading to protrusion of edematous polyps in the nasal cavity. Prevalence of NP among the chronic rhinosinusitis patients is 25-30 %. NP leads to significant limitations in physical, emotional and social aspects of life of the affected patients. Sleep disorder is frequently reported by those patients with impaired nasal breathing. Till now few studies have objectively assessed the impact of NP on sleep quality. the objectives are to figure out sleep disturbances in NP and to analyze the outcomes of sinus surgery on sleep recovering.
Eligibility Criteria
Inclusion Criteria: * Patients who underwent endoscopic sinus surgery for recalcitrant nasal polyposis (failure of a 4-month corticosteroid medical treatment) Social insured patient * Patient willing to comply with all procedures of the study and its duration * Patient giving consent Exclusion Criteria: * Patients with previous nasal surgery for nasal polyposis * Patients with previous continuous positive airway pressure therapy for obstructive sleep apnea * Non-coverage by the social security scheme * Patient unable to receive informed information * Refusal to sign the consent * Person deprived of the liberty * Person benefiting from a system of legal protection (guardianship…)
Contact & Investigator
Geoffrey Mortuaire, MD
PRINCIPAL INVESTIGATOR
University Hospital, Lille
Frequently Asked Questions
Who can join the NCT03725956 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Rhinosinusitis With Nasal Polyps. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03725956 currently recruiting?
Yes, NCT03725956 is actively recruiting participants. Contact the research team at geoffrey.mortuaire@chru-lille.fr for enrollment information.
Where is the NCT03725956 trial being conducted?
This trial is being conducted at Lille, France.
Who is sponsoring the NCT03725956 clinical trial?
NCT03725956 is sponsored by University Hospital, Lille. The principal investigator is Geoffrey Mortuaire, MD at University Hospital, Lille. The trial plans to enroll 30 participants.